Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
ALLO Allogene Therapeutics
- 1.680
- +0.140+9.09%
Close Apr 30 16:00 ET
- 1.670
- -0.010-0.60%
Post 18:47 ET
365.00MMarket Cap-1.27P/E (TTM)
1.700High1.510Low6.05MVolume1.530Open1.540Pre Close9.86MTurnover3.87%Turnover RatioLossP/E (Static)217.26MShares3.78052wk High0.86P/B262.67MFloat Cap1.23052wk Low--Dividend TTM156.35MShs Float55.000Historical High--Div YieldTTM12.34%Amplitude1.230Historical Low1.628Avg Price1Lot Size
Allogene Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.75%-200.3M | 31.67%-36.7M | 20.56%-44.12M | -2.80%-63.59M | 16.12%-55.9M | -7.81%-237.73M | 13.51%-53.71M | -16.53%-55.53M | -45.44%-61.86M | 2.34%-66.64M |
| Net income from continuing operations | 21.29%-257.59M | 30.12%-59.94M | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M |
| Operating gains losses | -84.18%1.69M | --0 | -54.57%1.13M | -115.40%-375K | -68.35%929K | -17.16%10.67M | -68.56%2.81M | 51.27%2.5M | 263.31%2.44M | -22.76%2.94M |
| Depreciation and amortization | -3.94%13.64M | -7.02%3.23M | -10.22%3.21M | 0.03%3.64M | 1.37%3.56M | -0.67%14.2M | 13.33%3.48M | -7.46%3.57M | -0.87%3.64M | -5.01%3.51M |
| Deferred tax | --443K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non cash items | -20.22%5.25M | -33.61%1.12M | -6.07%4.3M | -170.59%-96K | -136.90%-69K | 182.57%6.58M | 1,136.03%1.68M | 727.67%4.58M | -88.42%136K | -59.87%187K |
| Change In working capital | -16.39%-24.8M | 203.90%5.27M | 54.00%-8.88M | -284.26%-16.75M | -159.84%-4.44M | -646.75%-21.31M | -146.10%-5.07M | -347.82%-19.3M | -185.49%-4.36M | 137.12%7.42M |
| -Change in prepaid assets | -145.30%-492K | 172.99%1.8M | -115.57%-341K | -1,930.39%-1.87M | -106.81%-86K | -56.85%1.09M | -146.34%-2.47M | -61.61%2.19M | 105.54%102K | 118.93%1.26M |
| -Change in payables and accrued expense | 87.68%-1.77M | 18,312.50%2.91M | 71.83%-4.7M | 233.39%5.83M | -186.13%-5.81M | -316.49%-14.33M | -100.26%-16K | -663.81%-16.68M | -161.22%-4.37M | 170.59%6.74M |
| -Change in other current assets | 394.09%4.28M | 166.54%688K | 501.37%1.47M | 777.00%677K | 3,111.11%1.45M | 56.36%-1.46M | -740.65%-1.03M | 10.29%-366K | -132.15%-100K | 101.45%45K |
| -Change in other current liabilities | 142.39%259K | 2,275.00%95K | 1,816.67%115K | 720.00%41K | 101.28%8K | 67.53%-611K | -98.10%4K | 101.15%6K | 100.53%5K | 1.42%-626K |
| -Change in other working capital | -351.18%-27.08M | 85.29%-229K | ---5.42M | ---- | ---- | -28,480.95%-6M | -219.71%-1.56M | ---- | ---- | 82.35%-3K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.75%-200.3M | 31.67%-36.7M | 20.56%-44.12M | -2.80%-63.59M | 16.12%-55.9M | -7.81%-237.73M | 13.51%-53.71M | -16.53%-55.53M | -45.44%-61.86M | 2.34%-66.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -53.65%75.69M | -18.57%54.93M | -121.76%-75.99M | 334.81%74.61M | -80.40%22.13M | 53.82%163.29M | 36.02%67.46M | -237.59%-34.27M | -68.24%17.16M | 604.69%112.94M |
| Net PPE purchase and sale | 54.22%-694K | -41.99%-257K | -3,475.00%-429K | --0 | 99.23%-8K | 70.80%-1.52M | 89.30%-181K | 94.62%-12K | 79.04%-288K | 45.58%-1.04M |
| Net investment purchase and sale | -53.65%76.38M | -18.41%55.19M | -120.59%-75.56M | 327.63%74.61M | -80.57%22.14M | 48.01%164.81M | 31.88%67.64M | -236.32%-34.26M | -68.51%17.45M | 656.63%113.97M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -53.65%75.69M | -18.57%54.93M | -121.76%-75.99M | 334.81%74.61M | -80.40%22.13M | 53.82%163.29M | 36.02%67.46M | -237.59%-34.27M | -68.24%17.16M | 604.69%112.94M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 21.92%116.68M | 3,605.16%5.74M | -84.15%679K | 21.31%108.6M | -4.68%1.65M | 3,143.90%95.7M | 236.96%155K | 301.97%4.29M | 372,916.67%89.52M | -4.58%1.73M |
| Net common stock issuance | 22.98%112.05M | --5.74M | --0 | ---- | ---- | --91.11M | --0 | --3.19M | ---- | ---- |
| Proceeds from stock option exercised by employees | -48.77%2.35M | --0 | -37.76%679K | -98.82%19K | -4.68%1.65M | 55.36%4.58M | 236.96%155K | 2.35%1.09M | 6,591.67%1.61M | -4.58%1.73M |
| Net other financing activities | --2.28M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 21.92%116.68M | 3,605.16%5.74M | -84.15%679K | 21.31%108.6M | -4.68%1.65M | 3,143.90%95.7M | 236.96%155K | 301.97%4.29M | 372,916.67%89.52M | -4.58%1.73M |
| Net cash flow | ||||||||||
| Beginning cash position | 29.44%93.45M | -22.64%61.53M | 9.64%180.96M | -48.99%61.33M | 29.44%93.45M | -60.68%72.2M | -6.04%79.54M | 55.22%165.05M | 26.81%120.22M | -60.68%72.2M |
| Current changes in cash | -137.35%-7.94M | 72.40%23.98M | -39.66%-119.43M | 166.87%119.63M | -166.87%-32.12M | 119.07%21.25M | 211.69%13.91M | -294.36%-85.51M | 288.89%44.83M | 154.08%48.03M |
| End cash Position | -8.49%85.51M | -8.49%85.51M | -22.64%61.53M | 9.64%180.96M | -48.99%61.33M | 29.44%93.45M | 29.44%93.45M | -6.04%79.54M | 55.22%165.05M | 26.81%120.22M |
| Free cash flow | 15.99%-200.99M | 31.42%-36.96M | 19.80%-44.54M | -2.32%-63.59M | 17.39%-55.91M | -6.00%-239.25M | 15.52%-53.89M | -16.01%-55.54M | -41.54%-62.15M | 3.51%-67.67M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now